What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2022-11-14 compared with 2022-08-15 · 68 added, 42 removed, 23 unchanged (83% of the section changed)

OTHER INFORMATION

the quarter ended June 30, 2022, there have not been any material changes to the procedures by which security holders may recommend

the quarter ended September 30, 2022, there have not been any material changes to the procedures by which security holders may recommend

nominees to the Board of Directors.

following documents are filed as part of this report:

Share Exchange Agreement dated April 5, 2018 by and among Newmarkt Corp., the shareholders of Ozop Surgical, Inc., Ozop Surgical, Inc.

Exchange Agreement dated April 5, 2018 by and among Newmarkt Corp., the shareholders of Ozop Surgical, Inc., Ozop Surgical, Inc.

and Denis Razvodovskij (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on April 19, 2018).

Stock Purchase Agreement dated June 26, 2020, by and among Ozop Surgical Corp., Power Conversion Technologies, Inc.

and Catherine Chis (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on June 29, 2020).

Merger Agreement and Plan of Merger between Ozop Surgical Corp.

Purchase Agreement dated June 26, 2020, by and among Ozop Surgical Corp., Power Conversion Technologies, Inc.

and Catherine Chis

(Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on June 29, 2020).

Agreement and Plan of Merger between Ozop Surgical Corp.

and Ozop Surgical Name Change Subsidiary, Inc.

(Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on November 13, 2020).

Articles of Incorporation (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)

Bylaws (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)

Certificate of Amendment of Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on May 8, 2018 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on May 14, 2018).

Certificate of Designations for Series B Preferred Stock.

(Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on April 2, 2019).

Amended and Restated Bylaws of Ozop Surgical Corp.

(Incorporated by reference

to Exhibit 2.1 of the Current Report on Form 8-K filed on November 13, 2020).

of Incorporation (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)

(Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)

of Amendment of Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on May 8, 2018 (Incorporated

by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on May 14, 2018).

of Designations for Series B Preferred Stock.

(Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on

April 2, 2019).

and Restated Bylaws of Ozop Surgical Corp.

adopted on May 22, 2019.

(Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on May 22, 2019).

Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on July 25, 2019.

(Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 30, 2019).

Certificate of Designation of Series C Preferred Stock.

(Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on September 24, 2019).

Certificate of Withdrawal of Series B Preferred Stock.

(Incorporated by reference to Exhibit 3.2 of the Current Report

on Form 8-K filed on May 22, 2019).

and Restated Articles of Incorporation as filed with the Nevada Secretary of State on July 25, 2019.

(Incorporated by reference to

Exhibit 3.1 of the Current Report on Form 8-K filed on July 30, 2019).

of Designation of Series C Preferred Stock.

(Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on

September 24, 2019).

of Withdrawal of Series B Preferred Stock.

(Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on September

Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on October 29, 2019.

(Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on October 31, 2019).

Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on December 30, 2020, (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on December 31, 2019).

Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on January 21, 2020.

(Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 7, 2020).

Amended and Restated Certificate of Designation of Series C Preferred Stock.

(Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 5, 2020).

Amendment to Certificate of Designation of Series C Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 10, 2020).

Certificate of Designation of Series D Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on July 10, 2020).

Certificate of Designation of Series E Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K filed on July 10, 2020).

Articles of Incorporation of Ozop Surgical Name Change Subsidiary, Inc.

(Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on November 13, 2020).

Articles of Merger between Ozop Surgical Corp.

and Restated Articles of Incorporation as filed with the Nevada Secretary of State on October 29, 2019.

(Incorporated by reference

to Exhibit 3.2 of the Current Report on Form 8-K filed on October 31, 2019).

and Restated Articles of Incorporation as filed with the Nevada Secretary of State on December 30, 2020, (Incorporated by reference

to Exhibit 3.1 of the Current Report on Form 8-K filed on December 31, 2019).

and Restated Articles of Incorporation as filed with the Nevada Secretary of State on January 21, 2020.

(Incorporated by reference

to Exhibit 3.1 of the Current Report on Form 8-K filed on February 7, 2020).

and Restated Certificate of Designation of Series C Preferred Stock.

(Incorporated by reference to Exhibit 3.1 of the Current Report

on Form 8-K filed on February 5, 2020).

to Certificate of Designation of Series C Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.1 of the Current

Report on Form 8-K filed on July 10, 2020).

of Designation of Series D Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.2 of the Current Report on

Form 8-K filed on July 10, 2020).

of Designation of Series E Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.3 of the Current Report on

Form 8-K filed on July 10, 2020).

of Incorporation of Ozop Surgical Name Change Subsidiary, Inc.

(Incorporated by reference to Exhibit 3.1 of the Current Report on

Form 8-K filed on November 13, 2020).

of Merger between Ozop Surgical Corp.

and Ozop Surgical Name Change Subsidiary, Inc.

(Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on November 13, 2020).

Amended and Restated Certificate of Designation Series D Preferred Stock dated July 27, 2021 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on August 2, 2021).

Advisory agreement between Ozop Capital and RMA dated September 1, 2021 (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on September 2, 2021).

Binding Letter of Intent dated February 28, 2020, by and between Ozop Surgical Corp.

and Power Conversion Technologies, Inc, and Catherine Chis, (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on February 28, 2020).

Employment Agreement dated February 28, 2020, by and between Ozop Surgical Corp.

and Brian Conway, (Incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K filed on February 28, 2020).

Certification of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C.

(Incorporated by reference to Exhibit 3.2 of

the Current Report on Form 8-K filed on November 13, 2020).

and Restated Certificate of Designation Series D Preferred Stock dated July 27, 2021 (Incorporated by reference to Exhibit 3.1 of

the Current Report on Form 8-K filed on August 2, 2021).

agreement between Ozop Capital and RMA dated September 1, 2021 (Incorporated by reference to Exhibit 10.1 of the Current Report on

Form 8-K filed on September 2, 2021).

Letter of Intent dated February 28, 2020, by and between Ozop Surgical Corp.

and Power Conversion Technologies, Inc, and Catherine

Chis, (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on February 28, 2020).

Agreement dated February 28, 2020, by and between Ozop Surgical Corp.

and Brian Conway, (Incorporated by reference to Exhibit 10.3

of the Current Report on Form 8-K filed on February 28, 2020).

Certification

of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant

to Section 302 of the Sarbanes-Oxley Act of 2002

Certification

of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant

to Section 302 of the Sarbanes-Oxley Act of 2002

Certification

of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section

1350 of 18 U.S.C.

XBRL Instance Document

9 unchanged sentences

the undersigned thereunto duly authorized.

August 15, 2022

November 14, 2022

Brian P Conway

3 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information